tesamorelin and retatrutide together the Combined Playbook Retatrutide vs Tesamorelin vs GHK-Cu

GLP-1 activation alone produces meaningful weight loss, as demonstrated by Semaglutide achieving approximately 15% reduction in clinical trials

By combining these therapies with guidance on nutrition, exercise, and healthy habits, we help patients reach their weight management goals safely and effectively

At doses of 7 mg and 14 mg per day, it is approved as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes, and to reduce the risk of major adverse cardiovascular events in adults with that condition who are at high cardiovascular risk

Left thigh one week, right thigh the next, is a legitimate rotation

Semaglutide hits one